Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

This multidisciplinary update of the Society of Radiologists in Ultrasound consensus
statement on liver elastography incorporates the large volume of new information available …

Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

Abstract Background & Aims Diagnostic criteria for metabolic associated fatty liver disease
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …

Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …

Abstract The World Federation for Ultrasound in Medicine and Biology has produced these
guidelines for the use of elastography techniques in liver diseases. For each available …

Objective We aimed to evaluate the performance of the newly developed deep learning
Radiomics of elastography (DLRE) for assessing liver fibrosis stages. DLRE adopts the …

Background Diagnostic tools for liver disease can now include estimation of the grade of
hepatic steatosis (S0 to S3). Controlled attenuation parameter (CAP) is a non-invasive …

Background Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease,
and among the non-invasive tests, controlled attenuation parameter (CAP) and liver stiffness …

Background & aims Alcohol is the most common cause of liver-related mortality and
morbidity. We therefore aimed to assess and compare the prognostic performance of …